| Holo-retinol-binding protein and its receptor STRA6 drive oncogenic transformation. | None |
| These data establish that holo-RBP and its receptor STRA6 are potent oncogenes and suggest that the pathway is a novel target for therapy of some human cancers. | None |
| STRA6 is down-regulated by miR-873 and plays an oncogenic role by activating Wnt/beta-catenin signalling in GC. | None |